MiR-21 and Tocilizumab interactions improve COVID-19 myocarditis outcomes

por Hossein Heydari, Amir, Ghaffari, Saeid, Khani, Zahra, Heydari, Sophia, Eskandari, Zakaria, Esmaeil Heidari, Mohammad
Publicado 2023

Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial

por Gohari, Sepehr, Reshadmanesh, Tara, Khodabandehloo, Hadi, Fathi, Mojtaba, Ahangar, Hassan, Arsang-Jang, Shahram, Ismail-Beigi, Faramarz, Ghanbari, Samin, Dadashi, Mohsen, Muhammadi, Muhammad Javad, Gohari, Sheida, Ghaffari, Saeid
Publicado 2021